Belgium, Feb. 2 -- Project Id: 124262
Description: Project description
A European biobank to support immunotherapy research
Immunotherapy for cancer has not lived up to its initial promise, and results from clinical trials are variable. Therefore, the need arises to be able to predict response to immunotherapy or design combination therapies. For this purpose, the EU-funded IMMUcan project is building a state-of-the-art biobank of biological samples from cancer patients for whom immunotherapy has failed. Through a centralised workflow, the consortium will collect, process and store samples from various clinical trials in a uniform way. The samples will undergo immunoprofiling with cutting-edge technologies to investigate tumour-immune sy...